CompletedNCT01028651
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
Studying Pulmonary arterial hypertension associated with portal hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- United Therapeutics
- Principal Investigator
- Rajan Saggar, MDUniversity of California, Los Angeles
- Intervention
- Treprostinil(drug)
- Enrollment
- 13 target
- Eligibility
- All sexes
- Timeline
- 2011 – 2013
Study locations (4)
- University of California, Los Angeles, Los Angeles, California, United States
- Emory Univeristy, Atlanta, Georgia, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- University of Texas, Southwestern Medical Center, Dallas, Texas, United States
Collaborators
University of California, Los Angeles · Brigham and Women's Hospital · University of Texas · Emory University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01028651 on ClinicalTrials.gov